Emmett Investment Management LP purchased a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 34,446 shares of the real estate investment trust's stock, valued at approximately $2,387,000. National Health Investors makes up 2.1% of Emmett Investment Management LP's holdings, making the stock its 22nd biggest holding. Emmett Investment Management LP owned about 0.08% of National Health Investors as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in NHI. Norges Bank acquired a new position in shares of National Health Investors during the fourth quarter worth approximately $42,322,000. Balyasny Asset Management L.P. acquired a new position in National Health Investors during the fourth quarter worth $23,917,000. Marshall Wace LLP raised its stake in National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock worth $38,225,000 after acquiring an additional 340,712 shares in the last quarter. Centersquare Investment Management LLC grew its holdings in shares of National Health Investors by 35.9% during the fourth quarter. Centersquare Investment Management LLC now owns 394,433 shares of the real estate investment trust's stock worth $27,334,000 after purchasing an additional 104,186 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of National Health Investors by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 6,423,210 shares of the real estate investment trust's stock worth $445,128,000 after purchasing an additional 102,012 shares during the last quarter. Institutional investors own 62.51% of the company's stock.
National Health Investors Price Performance
NHI traded down $1.16 on Wednesday, reaching $73.47. The stock had a trading volume of 72,070 shares, compared to its average volume of 225,109. National Health Investors, Inc. has a fifty-two week low of $63.91 and a fifty-two week high of $86.13. The firm has a 50-day moving average of $74.20 and a 200-day moving average of $72.75. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $3.43 billion, a price-to-earnings ratio of 25.25, a price-to-earnings-growth ratio of 4.42 and a beta of 0.78.
National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The company had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.10 EPS. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current year.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.90%. The ex-dividend date is Monday, June 30th. National Health Investors's payout ratio is 114.29%.
Wall Street Analyst Weigh In
Several research firms recently issued reports on NHI. Truist Financial raised their price target on National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a report on Wednesday, March 19th. Wedbush reaffirmed an "outperform" rating and set a $88.00 price target on shares of National Health Investors in a research report on Monday, March 17th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $85.50.
Check Out Our Latest Report on National Health Investors
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.